Internal Medicine, Critical Care Medicine · Bay Shore, NY
NPI
1912072992
Since 2006
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
370 East Main Street, Suite 5
Bay Shore, NY, 11706
Phone (631) 666-5864
Groups this clinician bills Medicare through
Medicare paid, 2024
$200K
2,716 services
Medicare patients, 2024
735
Average age 74
Drug cost, 2024
$1.9M
2,916 prescriptions
Company payments, 2024
$17.02
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronald A Zielinski was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 565 times for 431 patients. In total Ronald A Zielinski billed 2,716 services in 24 codes, and Medicare paid $200K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-07-28.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 565 | 431 | $14.79 | $8,356 |
| 99214 Office E&M - Established | Office | 533 | 379 | $108.39 | $58K |
| 99215 Office E&M - Established | Office | 465 | 344 | $158.38 | $74K |
| 94010 Pulmonary Function Testing | Office | 442 | 335 | $24.23 | $11K |
| 94727 Pulmonary Function Testing | Office | 111 | 99 | $40.27 | $4,470 |
| 94729 Pulmonary Function Testing | Office | 111 | 99 | $50.86 | $5,646 |
| 85018 Blood Count | Office | 110 | 98 | $2.28 | $251 |
| 99204 Office E&M - New | Office | 81 | 81 | $140.30 | $11K |
| G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 63 | 53 | $31.13 | $1,961 |
| 99213 Office E&M - Established | Office | 56 | 50 | $81.56 | $4,567 |
| 99205 Office E&M - New | Office | 54 | 54 | $189.03 | $10K |
| 99233 Hospital E&M - Subsequent | Facility | 44 | 39 | $105.76 | $4,654 |
| 99406 Behavioral Health Services | Office | 28 | 24 | $16.43 | $460 |
| 99443 Telephone Services | Office | 15 | 15 | $108.06 | $1,621 |
| 99223 Hospital E&M - Initial | Facility | 12 | 12 | $156.44 | $1,877 |
By year: 2022 $197K for 2,156 services; 2023 $201K for 2,218 services; 2024 $200K for 2,716 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85018 Blood Count | 110 | 98 | $2.28 | $251 |
Medicare prescription drug claims, 2024
In 2024, the drug Ronald A Zielinski prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 538 prescriptions and refills. In total Ronald A Zielinski wrote 2,916 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 538 | 1,043 | 157 | $648K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 359 | 622 | 156 | $20K |
| Breo Ellipta Fluticasone/Vilanterol | 354 | 684 | 91 | $263K |
| Azelastine Hcl Generic | 151 | 254 | 62 | $4,116 |
| Prednisone Generic | 149 | 187 | 93 | $676 |
| Montelukast Sodium Generic | 133 | 381 | 44 | $1,551 |
| Fluticasone Propionate Generic | 121 | 282 | 51 | $2,403 |
| Arnuity Ellipta Fluticasone Furoate | 83 | 143 | 24 | $32K |
| Famotidine Generic | 82 | 140 | 25 | $505 |
| Mometasone Furoate Generic | 78 | 124 | 32 | $6,427 |
| Incruse Ellipta Umeclidinium Bromide | 71 | 141 | 18 | $47K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 61 | 115 | 23 | $11K |
| Ventolin Hfa Albuterol Sulfate | 60 | 97 | 18 | $5,367 |
| Dupixent Syringe Dupilumab | 48 | 48 | Under 11 | $201K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 35 | 91 | 15 | $41K |
Brand drugs: 1,729 claims; generic drugs: 1,187 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Ronald A Zielinski $17.02 ($17.02 in general payments such as food, travel and fees) from 1 company. The largest payer was Inspire Medical Systems, Inc. with $17.02.
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. INSP | 1 | $17.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.